Keratoconus is a progressive eye disease which occurs in one in 1,000 people and often begins in adolescence and adulthood.
What is Keratoconus?
The condition occurs in approximately 1 in 1000 people with varying degrees. Since the cornea is responsible for refracting most of the light coming into your eye, developing an irregular cornea can cause blurred vision.
As the disease progresses and the cornea thins, becoming increasingly irregular in shape, glasses and soft contacts no longer provide adequate vision correction.
Corneal Cross-Linking (CXL)
While the treatment will not correct vision or eliminate the need for glasses and/or contact lenses, it can help maintain the current level of vision and is meant to prevent vision from worsening. It can also facilitate the use of contact lenses.
CXL + T-PRK
Corneal Collagen Cross-Linking with Riboflavin (CXL) is a proven treatment, which effectively halts the progression of keratoconus.
Am I a candidate for CXL?
The only way to know if you are a candidate for CXL is to complete a free consultation.
What to expect
With Corneal Collagen Cross-Linking (CXL), there are no injections, stitches or incisions. It is performed by a highly skilled surgeon who is a corneal specialist.
Find out what this procedure has to offer and how this is made feasible to everyone’s reach.
A detailed study of Corneal Cross-Linking procedure by most prestigious doctors.